SMC– SARS-COV-2 RBD IGG KIT

General description

Immunoassay-based serology techniques play key roles in many SARS-CoV-2 research programs due to their ability to identify and characterize sample of infected individuals long after initial exposure. However, many traditional assay platforms, due to limitations in sensitivity and resolution, may not be truly optimal for use in situations where low-level characterization and stratification of SARS-CoV-2 antibody responses are essential, such as population studies, temporal infection timecourse experiments, and evaluating vaccine efficacy.

The SMC SARS-CoV-2 RBD IgG Kit contains all reagents required to perform the assay. This assay takes advantage of a standard immunoassay workflow configured in a standard plate format. Assay protocols are similar to existing sandwich ELISA methods with two key differences: 1) Elution buffer disrupts the sandwich, separating the labeled detection antibody for quantification. 2) The Erenna and SMCxPRO immunoassay systems detect analytes using Single Molecule Counting (SMC) technology.

Application

This new streamline kit has the following features including:

• For use with the state of the art TM=["SMCxPRO"] Ultrasensitive Immunoassay System

• Qualitative assay; for research use only<br />• Detects SARS-CoV-2 RBD specific IgG antibody within 3 days of PCR positive result

• Requires as little as 2?L of human serum and plasma sample (1:50 recommended dilution)

• Fast assay protocol (one hour capture, 30 minute detection steps)

Components

Assay Buffer SARS-CoV-2 RBD IgG Beads Standard Diluent SARS-CoV-2 RBD IgG Detection Antibody 10X Wash Buffer Buffer D Elution Buffer B

Legal Information

SMC is a registered trademark of Singulex

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.